We are developing a novel drug platform of drug candidates designed to trap aldehydes – toxic chemical species implicated in many serious diseases.
With a family of chemical entities, Aldeyra is first focusing on orphan diseases thought to be related to aldehydes.
To stay informed on future news,
click here to sign-up
for our email updates.